Inventia Healthcare Limited Glimepiride Export Data — India (DGFT 2022–2026)

Name: Inventia Healthcare Limited Glimepiride Export Records India — #4 Exporter, 108 Shipments, $3.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Glimepiride

India Pharmaceutical Trade Intelligence

$76.3M242 Suppliers94 CountriesHS 30049099

ExportsIndia → UNITED STATES67.1%India → SOUTH AFRICA4.8%

ImportsMALTA → India$43.6K GREECE → India$5.3K

#1 Supplier: INDOCO REMEDIES #1 Buyer: EVERSANA LIFE

Inventia Healthcare Limited — Glimepiride Exporter #4 | $3.0M Trade Value | TransData Nexus | TransData Nexus

Inventia Healthcare Limited — Glimepiride Exporter Profile

Indian Pharmaceutical Exporter · #4 for Glimepiride · $3.0M export value · DGFT Verified

Inventia Healthcare Limited is the #4 Indian exporter of Glimepiride with $3.0M in export value and 108 verified shipments. Inventia Healthcare Limited holds a 3.9% market share in Glimepiride exports across 6 countries. The company exports 11 pharmaceutical products worth $36.5M across 6 therapeutic categories.

Inventia Healthcare Limited — Glimepiride Export Profile: Buyers & Destinations

Inventia Healthcare Limited Glimepiride export treemap — buyers and destination countries | TransData Nexus

Where Does Inventia Healthcare Limited Export Glimepiride?

Country	Value	Shipments	Share
PHILIPPINES	$760.5K	22	28.1%
MALAYSIA	$626.5K	20	23.1%
VIETNAM DEMOCRATIC REP. OF	$434.4K	13	16.0%
NIGERIA	$364.1K	23	13.4%

Who Are the Top Buyers of Glimepiride from Inventia Healthcare Limited?

Buyer	Country	Value	Orders
I.E. MEDICA INC.	PHILIPPINES	$555.4K	15
MAXXCARE COMPANY LIMITED	VIETNAM DEMOCRATIC REP. OF	$434.4K	13
HEALOL PHARMACEUTICALS SDN. BHD.,	MALAYSIA	$375.5K	12
MAXXCARE COMPANY LIMITED.	VIETNAM, DEMOCRATIC REP. OF	$297.2K	8
MAY AND BAKER NIGERIA PLC	NIGERIA	$167.5K	7
HEALOL PHARMACEUTICALS SDN BHD	MALAYSIA	$156.3K	5
NOVOSWISS PHARMACEUTICALS, S.A	GAUTEMALA	$155.0K	8
I E MEDICA INC	PHILIPPINES	$150.0K	3
TO ZENITH BANK PLC	NIGERIA	$120.3K	4
TO THE ORDER OF,	NIGERIA	$44.0K	3

Inventia Healthcare Limited supplies Glimepiride to 22 buyers globally. The largest buyer is I.E. MEDICA INC. (PHILIPPINES), followed by MAXXCARE COMPANY LIMITED (VIETNAM DEMOCRATIC REP. OF) and HEALOL PHARMACEUTICALS SDN. BHD., (MALAYSIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Glimepiride Formulations Does Inventia Healthcare Limited Export?

Product Description / Formulation	Value	Shipments
LUPIMET (GLIMEPIRIDE 2MG AND METFORMIN H	$200.0K	4
PERGLIM M -2 (EACH TABLET CONTAIN: GLIMEPIRIDE USP 2 MG & METFORMIN HCL BP 500MG)NOS	$150.0K	3
PROGLUTROL G2 (GLIMEPIRIDE 2 MG AND METFORMIN HYDROCHLORIDE 500MG SUSTAINED RELEASE TABLETS) (MAL 12020010A)	$126.9K	4
PROGLUTROL G2 (GLIMEPIRIDE 2 MG AND METF	$125.8K	4
PERGLIM M -1 (EACH TABLET CONTAIN: GLIMEPIRIDE USP 1 MG & METFORMIN HCL BP 500MG) AS PER INVNOS	$114.8K	3
PERGLIM M-2 (EACH TABLET CONTAIN: GLIMEPIRIDE USP 2 MG & METFORMIN HCl BP 500 MG)	$97.8K	2
CO-MEPIRYL FORTE-(GLIMEPIRIDE 2MG AND ME	$86.9K	2
PERGLIM M -1 (EACH TABLET CONTAIN: GLIMEPIRIDE USP 1 MG & METFORMIN HCL BP 500 MG) AS PER INVNOS	$69.1K	3
LUPIMET (GLIMEPIRIDE 2MG AND METFORMIN HYDROCHLORIDE SUSTAINED RELEASE 500MG TABLETS)(ACT. QTY: 32700 X 3X10)NOS	$52.9K	3
LUPIMET (GLIMEPIRIDE 2MG AND METFORMIN HYDROCHLORIDE SUSTAINED RELEASE 500MG TABLETS) (ACT.QTY. 32373 CRTNS X 3X10)	$52.4K	3

Inventia Healthcare Limited exports 80 distinct Glimepiride formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LUPIMET (GLIMEPIRIDE 2MG AND METFORMIN H with 4 shipments worth $200.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Inventia Healthcare Limited Compare to Nearest Glimepiride Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	MICRO LABS LIMITED	$5.3M	439	18	$12.1K
3	IPCA LABORATORIES LIMITED	$3.6M	90	3	$40.0K
4	INVENTIA HEALTHCARE LIMITED ★	$3.0M	108	6	$27.6K
5	MEDREICH LIMITED	$2.1M	42	1	$50.0K
1	INDOCO REMEDIES LIMITED	$2.0M	41	2	$50.0K

Inventia Healthcare Limited ranks #4 among 242 Indian Glimepiride exporters. Average shipment value of $27.6K compared to the market average of $96.6K. The closest competitors by value are MICRO LABS LIMITED and IPCA LABORATORIES LIMITED.

Which Indian Ports Ship Glimepiride Exports?

Port	Shipments	% Share
SAHAR AIR	350	11.1%
NHAVA SHEVA SEA (INNSA1)	268	8.5%
SAHAR AIR CARGO ACC (INBOM4)	241	7.6%
DELHI AIR CARGO ACC (INDEL4)	228	7.2%
DELHI AIR	226	7.2%
JNPT/ NHAVA SHEVA SEA	172	5.4%
BANGALORE ACC (INBLR4)	148	4.7%
BANGALORE AIR	110	3.5%

Geopolitical & Trade Policy Impact on Inventia Healthcare Limited's Glimepiride Exports

Inventia Healthcare's extensive export operations are currently navigating a complex geopolitical landscape that presents both challenges and opportunities. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These logistical challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in supply chain management to mitigate potential delays and cost escalations. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced additional complexities for Indian pharmaceutical exporters. The imposition of tariffs on a broad range of imports, including pharmaceuticals, has raised concerns about cost competitiveness and market access. Companies like Inventia must navigate these policy shifts by exploring alternative markets and enhancing operational efficiencies to maintain their competitive edge. (apnews.com)

Conversely, the European Union's stringent regulatory frameworks, such as the Falsified Medicines Directive, necessitate rigorous compliance measures. While these regulations impose additional operational requirements, they also present an opportunity for companies with robust quality systems to differentiate themselves. Inventia's adherence to international quality standards positions it favorably to meet these regulatory demands and strengthen its presence in the European market.

Inventia Healthcare Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA and the European Medicines Agency intensifying their focus on manufacturing practices and product quality. For Indian exporters, this translates into the necessity for stringent compliance with Good Manufacturing Practices (GMP) and other regulatory standards.

Inventia Healthcare's manufacturing facility in Ambernath and its research and development center in Thane are accredited by the U.S. FDA, U.K. MHRA, and other stringent regulatory authorities. This compliance underscores the company's commitment to maintaining high-quality standards, facilitating access to both emerging and regulated markets. (platinumequity.com)

However, the broader Indian pharmaceutical sector faces challenges related to quality assurance, with instances of regulatory non-compliance affecting the industry's reputation. To mitigate these risks, companies like Inventia must continually invest in quality control systems, employee training, and process improvements to ensure sustained compliance and market trust.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Glimepiride shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Inventia Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 108 individual customs records matching Inventia Healthcare Limited exporting Glimepiride, covering 80 formulations to 8 countries via 22 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 94+ countries, 535+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Glimepiride

Glimepiride

Inventia Healthcare Limited — Glimepiride Exporter Profile

Inventia Healthcare Limited — Glimepiride Export Profile: Buyers & Destinations

Where Does Inventia Healthcare Limited Export Glimepiride?

Who Are the Top Buyers of Glimepiride from Inventia Healthcare Limited?

What Is India's Total Glimepiride Export Value and How Much Does Inventia Healthcare Limited Contribute?

What Is the Average Shipment Value for Inventia Healthcare Limited's Glimepiride Exports?

How Does Inventia Healthcare Limited Compare to Other Indian Glimepiride Exporters?

What Glimepiride Formulations Does Inventia Healthcare Limited Export?

How Does Inventia Healthcare Limited Compare to Nearest Glimepiride Exporters?

Which Indian Ports Ship Glimepiride Exports?

What Other Diabetes & Endocrine Products Does Inventia Healthcare Limited Export?

Glimepiride — Export Intelligence Video

Geopolitical & Trade Policy Impact on Inventia Healthcare Limited's Glimepiride Exports

Inventia Healthcare Limited — Regulatory Compliance & Quality Standards

About Inventia Healthcare Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Glimepiride Export Data from Inventia Healthcare Limited

Glimepiride Stats

Company Overview

Top Products by Inventia Healthcare Limited

Related Analysis

Need Detailed Export Data?

Data Source